Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Agree. When Brilacidin hits a mainstream press outlet lots more eyes will be on us in a flash. May be as soon as bottomline results release... someone deciding to do a more in depth compare/contrast with B and the competition.

Below a recent -- 10.29.14 -- Rx-ist targeted article on current ABSSSI meds: Vibativ, Dalvance, Orbactiv, and Sivextro

www.rxeconsult.com/healthcare-articles/New-Antibiotics-Vibativ-Dalvance-Orbactiv-and-Sivextro-for-Acute-Bacterial-Skin-Infection-ABSSSI-718/#.dpuf